The Current Ratio as of November 2024 (TTM) for BioMarin Pharmaceutical Inc. (BMRN) is 4.27

According to BioMarin Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.27. This represents a change of -51.44% compared to the average of 8.80 of the last 4 quarters.

BioMarin Pharmaceutical Inc. (BMRN) Historical Current Ratio (quarterly & annually)

How has BMRN Current Ratio performed in the past?

The mean historical Current Ratio of BioMarin Pharmaceutical Inc. over the last ten years is 3.66. The current 4.27 Current Ratio has changed 11.57% with respect to the historical average. Over the past ten years (40 quarters), BMRN's Current Ratio was at its highest in in the December 2023 quarter at 25.11. The Current Ratio was at its lowest in in the December 2019 quarter at 2.08.

BioMarin Pharmaceutical Inc. (BMRN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BioMarin Pharmaceutical Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioMarin Pharmaceutical Inc. (BMRN) Average Current Ratio

How has BMRN Current Ratio performed in the past?

The current Current Ratio of BioMarin Pharmaceutical Inc. (BMRN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioMarin Pharmaceutical Inc. (BMRN) Current Ratio vs. Peers

How is BMRN’s Current Ratio compared to its peers?

BioMarin Pharmaceutical Inc.’s Current Ratio is greater than Seagen Inc. (2.67), greater than Alnylam Pharmaceuticals, Inc. (2.75), greater than Exelixis, Inc. (3.93), less than Halozyme Therapeutics, Inc. (10.36), less than Arrowhead Pharmaceuticals, Inc. (4.65), greater than Incyte Corporation (1.87), less than Ionis Pharmaceuticals, Inc. (8.91), less than Apellis Pharmaceuticals, Inc. (4.36), less than Vaxcyte, Inc. (17.88), less than Liquidia Corporation (6.33), less than Legend Biotech Corporation (4.98), less than Bio-Techne Corporation (4.56), less than Mereo BioPharma Group plc (6.10), greater than Blueprint Medicines Corporation (3.32), less than Agios Pharmaceuticals, Inc. (8.99), less than Day One Biopharmaceuticals, Inc. (14.62), less than IVERIC bio, Inc. (18.63), less than Amylyx Pharmaceuticals, Inc. (4.55), less than Karuna Therapeutics, Inc. (19.31),

Build a custom stock screener for BioMarin Pharmaceutical Inc. (BMRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMarin Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioMarin Pharmaceutical Inc. (BMRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioMarin Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.